Correlation Between Biomarin Pharmaceutical and Wave Life
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and Wave Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and Wave Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and Wave Life Sciences, you can compare the effects of market volatilities on Biomarin Pharmaceutical and Wave Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of Wave Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and Wave Life.
Diversification Opportunities for Biomarin Pharmaceutical and Wave Life
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Biomarin and Wave is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and Wave Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wave Life Sciences and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with Wave Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wave Life Sciences has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and Wave Life go up and down completely randomly.
Pair Corralation between Biomarin Pharmaceutical and Wave Life
Given the investment horizon of 90 days Biomarin Pharmaceutical is expected to under-perform the Wave Life. But the stock apears to be less risky and, when comparing its historical volatility, Biomarin Pharmaceutical is 3.09 times less risky than Wave Life. The stock trades about -0.28 of its potential returns per unit of risk. The Wave Life Sciences is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 1,467 in Wave Life Sciences on August 24, 2024 and sell it today you would lose (32.00) from holding Wave Life Sciences or give up 2.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biomarin Pharmaceutical vs. Wave Life Sciences
Performance |
| Timeline |
| Biomarin Pharmaceutical |
| Wave Life Sciences |
Biomarin Pharmaceutical and Wave Life Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomarin Pharmaceutical and Wave Life
The main advantage of trading using opposite Biomarin Pharmaceutical and Wave Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, Wave Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wave Life will offset losses from the drop in Wave Life's long position.| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
| Wave Life vs. Lyra Therapeutics | Wave Life vs. Hookipa Pharma | Wave Life vs. Cingulate Warrants | Wave Life vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |